References

  1. Miller MT, Strömland K. Teratogen Update: Thalidomide: A Review, With a Focus on Ocular Findings and New Potential Uses. TERATOLOGY. 1999; 60(5):306?321. PubMed | Google Scholar

  2. Garazzino S, Lutsar I, Bertaina C, Tovo PA, Sharland M. New antibiotics for paediatric use: a review of a decade of regulatory trials submitted to the European Medicines Agency from 2000--why aren't we doing better? Int J Antimicrob Agents. 2013; 42(2):99-118. PubMed | Google Scholar

  3. Ferrajolo C, Verhamme KM, Trifirò G, 't Jong GW, Giaquinto C, Picelli G, Oteri A, de Bie S, Valkhoff VE, Schuemie MJ, Mazzaglia G, Cricelli C, Rossi F, Capuano A, Sturkenboom MC. Idiopathic acute liver injury in paediatric outpatients: incidence and signal detection in two European countries. Drug Saf. 2013; 36(10):1007-1016. PubMed | Google Scholar

  4. Marcus KA, Sorbello A, Truffa M, Williams J, Raine JM, Powderly WG. Current advances in pharmacovigilance in the USA and Europe: meeting the challenges of safety monitoring in HIV. Curr Opin HIV AIDS. 2012; 7(4):292-298. PubMed | Google Scholar

  5. Awodele O, Daniel A, Popoola TD, Salami EF. A study on pharmacovigilance of herbal medicines in Lagos West Senatorial District, Nigeria. Int J Risk Saf Med. 2013; 25(4):205-217. PubMed | Google Scholar

  6. Osakwe A, Oreagba I, Adewunmi AJ, Adekoya A, Fajolu I. Impact of training on Nigerian healthcare professionals' knowledge and practice of pharmacovigilance. Int J Risk Saf Med. 2013; 25(4):219-227. PubMed | Google Scholar

  7. Blatt A, Chambon R, Lemardeley P. Legal format and costs of prescriptions at the Central Hospital in Yaounde, Cameroon. Med Trop. 1997; 57(1):37-40. PubMed | Google Scholar

  8. Brasseur P Mt, Olliaro PL. Anti-malarial drug safety information obtained through routine monitoring in a rural district of South-Western Senegal. Malar J. 2012; 11:402. PubMed | Google Scholar

  9. Sevene E, Mariano A, Mehta U, Machai M, Dodoo A, Vilardell D, and al. Spontaneous adverse drug reaction reporting in rural districts of Mozambique. Malar J. 2010; 12:335. PubMed | Google Scholar

  10. Ohaju O, Iribhogbe O. Pharmacoepidemiology drug. Extends of pharmacovigilance among resident doctors in Edo and Lagos states of Nigeria. 2010; 19(2):191-195. PubMed | Google Scholar

  11. Santosh K, Tragulpiankit P, Edwards I, Gorsanan S. Knowledge about adverse drug reactions reporting among healthcare professionals in Nepal. Int J Risk Saf Med. 2013; 25(1):1-16. PubMed | Google Scholar

  12. Breugelmans J, Lewis R, Agbenu E, Veit O, Jackson D, Domingo C, and al. Adverse events following yellow fever preventive vaccination campaigns in eight African countries from 2007 to 2010. Elsevier. 2013; (14):1819-1829. Google Scholar

  13. Diouf M, Bodian S, Lo CM, Cisse D, Faye D, Touré B, Fall M. Sante Publique. [Pharmacovigilance among dentists: a survey of practitioners in Dakar, Senegal]. 2013; 25(1):69-76. PubMed | Google Scholar